本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cogent Biosciences, Inc.

32.74
-0.6700-2.01%
盤後32.910.1700+0.52%19:48 EDT
成交量:171.24萬
成交額:5,647.77萬
市值:56.81億
市盈率:-15.16
高:33.93
開:33.37
低:32.69
收:33.41
52周最高:43.73
52周最低:11.60
股本:1.74億
流通股本:1.67億
量比:0.93
換手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
淨資產收益率:-109.74%
總資產收益率:-43.84%
市淨率:12.15
市盈率(LYR):-12.84

資料載入中...

2026/09/03

重要事件披露

Form 8-K - Current report
2026/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/17

重要事件披露

Form 8-K - Current report
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities